People with Parkinson’s disease are receiving a new treatment in a clinical trial started after University of Wisconsin-Madison scientists demonstrated the safety and feasibility of the therapeutic delivery method in a study of non-human primates.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
